BioSpace News Archive

Pfizer Inc. (NYSE: PFE) today announced that its 2020 Annual Meeting of Shareholders will be held in a virtual-only format due to continued public health concerns related to coronavirus / COVID-19, and to support the health and well-being of our shareholders and other meeting participants

Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, for the treatment of patients with various solid tumor malignancies, today announced that the proposed merger agreement with Organovo Holdings, Inc.

Canadian public health guidance related to COVID-19 has been changing as the evidence base and our understanding of COVID-19 is rapidly evolving.

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

Willow Biosciences Inc. (“Willow” or “the Company”) (TSX: WLLW; OTCQB: CANSF) announces changes to its management team with the promotion of Dr. Chris Savile to Chief Operations Officer and the departure of Dr. Peter Facchini, Chief Scientific Officer, and Dr. Jill Hagel, Vice President, Applied Science, effective immediately.

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines based in both Perth, Australia and Philadelphia, is pleased to announce it has received the final report for its ZTL-101 medicinal cannabis trial for insomnia.

Serological tests measure the amount of antibodies or proteins present in the blood when the body is responding to a specific infection, like COVID-19.

Cryosauna manufacturer pivots production to manufacture oxygen hoses for hospital staff in New York City—and around the country— who are desperate to save the lives of individuals battling COVID-19.

Global Medical Ventilator Market: Increasing incidences of respiratory failure, rise in healthcare expenditure and surge in number of chronic disordersdriving the growth of the medical ventilator market.

BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it is offering substance use disorder (SUD) medical professionals free access to the BioCorRx® Recovery mobile platform for a limited time to enable them to “see” their patients virtually during the coronavirus pandemic.